DC
INFI

Deere & Company’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Deere & Company’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-28,558
Closed -$399K – 1125
2015
Q1 		$399K Buy
28,558
+15,721
+122% +$240K 0.02% 706
2014
Q4 		$217K Buy
+12,837
New +$187K 0.01% 844

Other funds holding INFI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's INFI Position: Q2 2015 in Review

Deere & Company sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2015, closing a stake of 28,558 shares — an estimated $399K sold.

Deere & Company first reported a position in INFI in Q4 2014 and held it in 2 quarters. The position peaked at $399K in Q1 2015. 137 funds tracked by Wall St. Rank hold INFI as of Q2 2015.

  • Deere & Company reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 28,558 Infinity Pharmaceuticals, Inc. shares in Q2 2015, an estimated $399K.
  • Deere & Company first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
  • Deere & Company's Infinity Pharmaceuticals, Inc. position peaked at $399K in Q1 2015.
  • 137 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.